IRIS
LANINI, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.309
NA - Nord America 1.087
EU - Europa 614
SA - Sud America 569
AF - Africa 34
OC - Oceania 4
Totale 4.617
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 1.076
US - Stati Uniti d'America 1.023
BR - Brasile 471
CN - Cina 356
HK - Hong Kong 342
VN - Vietnam 206
IT - Italia 182
RU - Federazione Russa 111
FR - Francia 98
BD - Bangladesh 93
KR - Corea 80
GB - Regno Unito 39
AR - Argentina 36
DE - Germania 36
NL - Olanda 32
IN - India 29
ID - Indonesia 28
CA - Canada 25
MX - Messico 23
EC - Ecuador 18
IQ - Iraq 17
AT - Austria 16
SE - Svezia 13
TR - Turchia 13
ES - Italia 12
FI - Finlandia 12
IE - Irlanda 10
CO - Colombia 9
UA - Ucraina 9
ZA - Sudafrica 9
JP - Giappone 8
PK - Pakistan 8
PY - Paraguay 8
VE - Venezuela 8
CL - Cile 7
UY - Uruguay 7
KZ - Kazakistan 6
PL - Polonia 6
RO - Romania 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CH - Svizzera 4
EG - Egitto 4
GE - Georgia 4
KE - Kenya 4
MA - Marocco 4
PE - Perù 4
UZ - Uzbekistan 4
AU - Australia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
BG - Bulgaria 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 4.617
Salva come PNG Salva come JPEG
Città #
Singapore 490
Hong Kong 339
Ashburn 167
Beijing 134
San Jose 110
Lauterbourg 88
Boardman 83
Hefei 79
Seoul 79
Ho Chi Minh City 69
Los Angeles 65
Dallas 64
Santa Clara 48
Hanoi 45
Redondo Beach 38
Buffalo 37
The Dalles 34
São Paulo 32
New York 27
Council Bluffs 25
Amsterdam 15
Orem 13
Rio de Janeiro 13
Rome 13
Chennai 12
Milan 12
Udine 12
Montreal 11
Stockholm 11
Atlanta 10
Dublin 10
Frankfurt am Main 10
Guangzhou 10
Mexico City 10
Da Nang 9
Guayaquil 9
Haiphong 9
Vienna 9
Brooklyn 8
Chicago 8
Helsinki 8
Tokyo 8
Campinas 7
Houston 7
Jakarta 7
Nuremberg 7
Pelotas 7
Porto Alegre 7
Quito 7
Tombolo 7
Wuhan 7
Baghdad 6
Bari 6
Brasília 6
Curitiba 6
Dhaka 6
Düsseldorf 6
Montevideo 6
Mumbai 6
Naples 6
Shenzhen 6
Warsaw 6
Asunción 5
Belford Roxo 5
Belo Horizonte 5
Biên Hòa 5
Cuiabá 5
Denver 5
Feira de Santana 5
Ha Long 5
Johannesburg 5
Phoenix 5
Ribeirão Preto 5
São José dos Campos 5
Thái Bình 5
Toronto 5
Ankara 4
Belluno 4
Bologna 4
Buenos Aires 4
Dong Ket 4
Goiânia 4
Itaquaquecetuba 4
Joinville 4
London 4
Maceió 4
Manchester 4
Milwaukee 4
Osasco 4
Phủ Lý 4
Quảng Ninh 4
Tashkent 4
Thái Nguyên 4
Vancouver 4
Xi'an 4
Athens 3
Baku 3
Bauru 3
Bogotá 3
Boston 3
Totale 2.573
Salva come PNG Salva come JPEG
Nome #
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 138
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 107
Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: Outbreak investigation and infection outcome 96
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 87
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 87
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study 84
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials 84
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 79
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 76
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study) 72
The middle east respiratory syndrome coronavirus – a continuing risk to global health security 71
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 65
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study 65
Benefits of steroid therapy in COVID-19 patients with different PaO2/FiO2 ratio at admission 65
Blood kinetics of Ebola virus in survivors and nonsurvivors 65
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient 64
Risk of infection in patients with lymphoma receiving rituximab: Systematic review and meta-analysis 63
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital: USE OF ANTIVIRALS FOR MONKEYPOX IN AN ITALIAN HOSPITAL 63
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study 62
Escherichia coli producing AmpC DHA-1 bacteraemia in neutropenic leukemic patient: continuous infusion ceftazidime/avibactam as a carbapenem sparing regimen 62
COVID-19 disease - Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study 62
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 61
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH 60
Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians 59
Appropriateness of surgical antimicrobial prophylaxis in the Latium Region of Italy, 2008: A multicenter study 59
A large epidemic of hepatitis B in Serbia: An integrated model for outbreak investigations in healthcare settings 59
Detection of recombinant breakpoint in the genome of human enterovirus E11 strain associated with a fatal nosocomial outbreak 57
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 57
Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects 57
Temporal intra-host variability of mpox virus genomes in multiple body tissues 56
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 55
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? 54
Noninvasive positive-pressure ventilation 54
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 54
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis 53
Author's reply: measles on a cruise ship--links with the outbreak in the Philippines 53
Patient to patient transmission of hepatitis B virus: A systematic review of reports on outbreaks between 1992 and 2007 52
Ebola virus disease complicated with viral interstitial pneumonia: A case report 51
Liver transplant recipients and prioritization of anti-HCV therapy: An Italian cohort analysis 50
Epidemiology of HEV in the mediterranean basin: 10-year prevalence in Italy 50
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study 49
Analysis of Diagnostic Findings from the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 48
Non-randomised Ebola trials-lessons for optimal outbreak research 48
Criteria for discharge of patients with Ebola virus diseases in high-income countries 47
Local transmission of chikungunya in Rome and the lazio region, Italy 47
Cefepime-Taniborbactam in Complicated Urinary Tract Infection 47
Pulmonary involvement during the Ebola virus disease 47
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH 47
Authors reply: measles on the cruise ship: links with virus spreading into an emergency department in Southern Italy 47
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19 46
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results 46
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves 46
Hepatitis C: global epidemiology and strategies for control 46
Viral hemorrhagic fevers: Advancing the level of treatment 46
Infections in patients taking Rituximab for hematologic malignancies: Two-year cohort study 46
Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome 45
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count 45
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV 45
Relationship between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study 44
Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant 44
Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: A nationwide surveillance study 44
Epidemiology of viral hepatitis in men who have sex with men in Mediterranean Europe: a region-wide sero-surveillance in Rome (Italy) 43
Hospital cluster of HBV infection: Molecular evidence of patient-to-patient transmission through lancing device 43
Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries 43
Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy 43
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study) 43
SELP Asp603Asn and severe thrombosis in COVID-19 males 43
Inflammatory and humoral immune response during ebola virus infection in survivor and fatal cases occurred in sierra leone during the 2014–2016 outbreak in west Africa 43
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years 43
High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: Evidence from outbreak investigation 42
Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser 42
Is hepatitis C virus eradication around the corner only 25 years after its discovery? 42
The added value of long-lasting preparedness for the management of a patient with Ebola 41
Risk management of febrile respiratory illness in emergency departments 41
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection 41
Influenza A (H1N1) in Rome, Italy in family: Three case reports 41
Short-term economic impact of the Zika virus outbreak 41
Ebola: Missed opportunities for Europe-Africa research 40
The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown 40
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox 40
The surveillance of chikungunya virus in a temperate climate: Challenges and possible solutions from the experience of Lazio Region, Italy 39
Reply to Reisler et al 39
Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach 39
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV 38
RE: Measles on the cruise ship: Links with virus spreading into an emergency department in southern Italy 38
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents 37
Hepatitis C virus treatment revolution: Need for close monitoring 36
SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy–July 2020 36
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 36
Measles cases during ebola outbreak, West Africa, 2013–2106 35
Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection 35
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? 31
Hiv/hcv co-infection: Putting the pieces of the puzzle together 31
HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study 28
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease 25
Totale 4.956
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/20224 0 0 0 0 0 0 0 0 0 1 2 1
2022/20232 1 0 0 0 0 1 0 0 0 0 0 0
2023/20247 0 0 0 0 1 0 0 3 0 1 0 2
2024/20251.893 1 464 206 30 45 66 61 64 111 67 351 427
2025/20263.040 144 283 525 483 398 217 285 104 102 226 273 0
Totale 4.956